Anesthesiology, Pain Medicine · Clearwater, FL
NPI
1215199609
Since 2008
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2250 Drew St
Clearwater, FL, 33765
Phone (727) 797-7463
Groups this clinician bills Medicare through
Medicare paid, 2024
$587K
10,930 services
Medicare patients, 2024
472
Average age 71
Drug cost, 2024
$1.6M
19,235 prescriptions
Company payments, 2025
$4,254
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nabil S Gerges was code 99214 (office e&m - established), 2,864 times for 439 patients. In total Nabil S Gerges billed 10,930 services in 63 codes, and Medicare paid $587K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,864 | 439 | $98.62 | $282K |
| 96130 Behavioral Health Services | Office | 589 | 276 | $88.69 | $52K |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 510 | 196 | $5.38 | $2,744 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 399 | 236 | $194.77 | $78K |
| 99406 Behavioral Health Services | Office | 350 | 75 | $14.24 | $4,985 |
| 20552 Musculoskeletal | Office | 244 | 102 | $40.37 | $9,851 |
| 76942 Ultrasound - Nonspecific | Office | 211 | 131 | $45.27 | $9,553 |
| 80305 Drug Tests | Office | 208 | 200 | $12.35 | $2,569 |
| 20550 Musculoskeletal | Office | 167 | 97 | $61.03 | $10K |
| 99213 Office E&M - Established | Office | 128 | 104 | $74.92 | $9,590 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 126 | 57 | $49.93 | $6,291 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 97 | 61 | $162.99 | $16K |
| 64493 Nerve Block Injection - Back | Facility | 95 | 58 | $112.07 | $11K |
| 62323 Nerve Block Injection - Back | Facility | 92 | 66 | $82.35 | $7,576 |
| 64494 Nerve Block Injection - Back | Facility | 90 | 55 | $63.94 | $5,755 |
By year: 2022 $713K for 12,951 services; 2023 $588K for 10,856 services; 2024 $587K for 10,930 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 399 | 236 | $194.77 | $78K |
| 80305 Drug Tests | 208 | 200 | $12.35 | $2,569 |
Medicare prescription drug claims, 2024
In 2024, the drug Nabil S Gerges prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 2,526 prescriptions and refills. In total Nabil S Gerges wrote 19,235 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,526 | 2,528 | 349 | $87K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,154 | 2,154 | 312 | $54K |
| Oxycodone Hcl Generic | 2,114 | 2,114 | 272 | $44K |
| Gabapentin Generic | 1,631 | 2,181 | 348 | $27K |
| Morphine Sulfate Er Morphine Sulfate | 1,385 | 1,386 | 181 | $32K |
| Tizanidine Hcl Generic | 1,084 | 1,406 | 238 | $18K |
| Pregabalin Generic | 691 | 755 | 137 | $13K |
| Meloxicam Generic | 652 | 804 | 156 | $2,390 |
| Cyclobenzaprine Hcl Generic | 588 | 721 | 132 | $8,141 |
| Naloxone Hcl Generic | 557 | 557 | 466 | $38K |
| Morphine Sulfate Generic | 428 | 428 | 64 | $13K |
| Baclofen Generic | 366 | 477 | 89 | $6,375 |
| Tramadol Hcl Generic | 339 | 342 | 67 | $4,327 |
| Trazodone Hcl Generic | 286 | 318 | 46 | $1,262 |
| Celecoxib Generic | 264 | 347 | 65 | $5,237 |
Brand drugs: 1,595 claims; generic drugs: 17,640 claims; opioid claims: 10,312.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nabil S Gerges $4,254 ($4,254 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbott Laboratories with $1,929.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 10 | $1,929 |
| Boston Scientific Corporation BSX | 9 | $423 |
| Globus Medical, Inc. GMED | 6 | $366 |
| Pfizer Inc. PFE | 15 | $352 |
| Collegium Pharmaceutical, Inc. COLL | 48 | $291 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 8 | $245 |
| Stryker Corporation SYK | 2 | $236 |
| Axsome Therapeutics, Inc. AXSM | 1 | $121 |
| Abbvie Inc. ABBV | 5 | $115 |
| Scilex Pharmaceuticals Inc. | 5 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.